Edward L Cahill Phreesia, Inc. (PHR) insider trading activity

Edward L Cahill is Director of Phreesia, Inc.. Currently has a direct ownership of 47,032 shares of PHR, which is worth approximately $868,681. The most recent transaction as insider was on Oct 31, 2024, when has been sold 546 shares (Common Stock) at a price of $18.29 per share, resulting in proceeds of $9,986. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47K

1.17% 3M change

4.03% 12M change

Total Value Held $868,681

EDWARD L CAHILL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 31 2024	BUY Grant, award, or other acquisition	$9,986 $18.29 p/Share	546 Added 1.15%	47,032 Common Stock
Jul 31 2024	BUY Grant, award, or other acquisition	$9,980 $24.95 p/Share	400 Added 0.85%	46,486 Common Stock
Jun 26 2024	BUY Grant, award, or other acquisition	-	8,490 Added 13.46%	54,576 Common Stock
Apr 30 2024	BUY Grant, award, or other acquisition	$9,996 $20.74 p/Share	482 Added 1.04%	46,086 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	$9,988 $25.48 p/Share	392 Added 0.85%	45,604 Common Stock
Oct 31 2023	BUY Grant, award, or other acquisition	$9,999 $13.66 p/Share	732 Added 1.59%	45,212 Common Stock
Jul 31 2023	BUY Grant, award, or other acquisition	$9,991 $31.72 p/Share	315 Added 0.7%	44,480 Common Stock
Jun 28 2023	BUY Grant, award, or other acquisition	-	6,051 Added 12.05%	44,165 Common Stock
Apr 28 2023	BUY Grant, award, or other acquisition	$9,998 $31.64 p/Share	316 Added 0.82%	38,114 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	$9,972 $37.49 p/Share	266 Added 0.7%	37,798 Common Stock
Oct 31 2022	BUY Grant, award, or other acquisition	$9,999 $27.32 p/Share	366 Added 0.97%	37,532 Common Stock
Jul 29 2022	BUY Grant, award, or other acquisition	$8,738 $23.49 p/Share	372 Added 0.99%	37,166 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	-	7,397 Added 16.74%	36,794 Common Stock
Apr 29 2022	BUY Grant, award, or other acquisition	$8,740 $22.88 p/Share	382 Added 1.28%	29,397 Common Stock
Jan 31 2022	BUY Grant, award, or other acquisition	$8,733 $31.19 p/Share	280 Added 0.96%	29,015 Common Stock
Oct 29 2021	BUY Grant, award, or other acquisition	$8,747 $70.54 p/Share	124 Added 0.43%	28,735 Common Stock
Jul 30 2021	BUY Grant, award, or other acquisition	$8,749 $68.35 p/Share	128 Added 0.45%	28,611 Common Stock
Jul 08 2021	BUY Grant, award, or other acquisition	-	2,605 Added 8.38%	28,483 Common Stock
Jun 24 2021	SELL Open market or private sale	$300,150 $60.03 p/Share	5,000 Reduced 16.19%	25,878 Common Stock
Jun 14 2021	SELL Open market or private sale	$864,750 $57.65 p/Share	15,000 Reduced 32.7%	30,878 Common Stock
Apr 30 2021	BUY Grant, award, or other acquisition	-	169 Added 0.37%	45,878 Common Stock
Apr 01 2021	SELL Open market or private sale	$824,850 $54.99 p/Share	15,000 Reduced 24.71%	45,709 Common Stock
Feb 18 2021	SELL Open market or private sale	$726,300 $72.63 p/Share	10,000 Reduced 14.14%	60,709 Common Stock
Dec 24 2020	SELL Open market or private sale	$1,394,451 $57.22 p/Share	24,370 Reduced 25.63%	70,709 Common Stock
Sep 29 2020	BUY Other acquisition or disposition	-	24,306 Added 20.36%	95,079 Common Stock

Also insider at

TNDM

TANDEM DIABETES CARE INC Healthcare

Director

ELC

Edward L Cahill

Director

Raleigh, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHR shares.

Notify only if

Value

Insider Trading

Get notified when an Phreesia, Inc. insider buys or sells PHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Phreesia, Inc.

Track Activities on PHR

Account